Overview

Update
Acquisitions
1 Acquisition
IPO / Stock
Went Public on Jul 25, 2014 / NASDAQ:CDNA
Headquarters:
Brisbane, CA
Description:
XDx is a novel mol­e­c­u­lar diagnos­tics com­pany.
Founders:
Categories:
Fitness, Health Care, Biotechnology, Health Diagnostics
Website:
http://www.xdx.com
Social:

Company Details

Update

Founded in 2000, XDx, Inc. is a molecular diagnostics company based in Brisbane, CA, USA. XDx applies modern genomics technologies to the development of molecular diagnostic assays that translate a patient's immune status into clinically actionable information. XDx has one marketed product, AlloMap Molecular Expression Testing, and other products under development. The proprietary molecular expression technology used by XDx to develop AlloMap testing for heart transplant patient management may be applicable to the post-transplant management of recipients of other organs. The application of gene expression testing to other diseases that involve the activity of the immune system, such as autoimmune and chronic inflammatory diseases, is also being explored.

Funding Rounds (11) - $182.74M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2016$22.17M / Post Ipo Equity0
Apr, 2016$14.17M / Venture0
Sep, 2012$15M / Debt Financing2
Nov, 2011$2.16M / Debt Financing0
Jan, 2011$12.5M / Grant1
Jul, 2010$6.04M / Debt Financing0
Oct, 2009$14.4M / Venture7
Aug, 2009$14.4M / Series F8
Jun, 2008$35.4M / Series E0
Jan, 2006$26.5M / Venture7
Dec, 2004$20M / Series D5

Acquisitions (1)

Update
DateAcquiredAmount
Dec 16, 2015$35M in Cash & Stock

Current Team (6)

Update

Offices/Locations (2)

Update
  • 3260 Bayshore Blvd

    Brisbane, CA 94005

    USA

  • Office

    3260 Bayshore Blvd.

    Brisbane, CA 94005

    USA

Past Team (9)

Update

Images (1)

Update

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos